Grifols reported EUR2.01B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 7M 2M Mar/2026
Arca Biopharma USD 1.34B 1.1B Aug/2026
Bio Path USD 0 1000K Aug/2026
Brainstorm Cell Therapeutics USD 43M 32M Aug/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cara Therapeutics USD 110M 80M Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Immunic USD 64M 23M Dec/2025
Nektar Therapeutics USD 12.98B 10.86B Aug/2026